Robert Bucki Selected Research

Gelsolin

2/2023	Plasma Gelsolin Enhances Phagocytosis of Candida auris by Human Neutrophils through Scavenger Receptor Class B.
1/2022	Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis.
4/2020	Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with Pseudomonas aeruginosa Sepsis.
7/2019	Susceptibility of microbial cells to the modified PIP2-binding sequence of gelsolin anchored on the surface of magnetic nanoparticles.
2/2019	Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis.
2/2019	Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin.
8/2018	Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.
1/2018	Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics.
6/2011	Therapeutic potential of plasma gelsolin administration in a rat model of sepsis.
1/2011	Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Bucki Research Topics

Disease

38	Infections 02/2024 - 06/2003
19	Neoplasms (Cancer) 01/2024 - 01/2014
19	Inflammation (Inflammations) 01/2023 - 09/2007
9	Cystic Fibrosis (Mucoviscidosis) 01/2024 - 06/2003
5	Sepsis (Septicemia) 04/2020 - 12/2008
4	COVID-19 07/2023 - 03/2021
4	Bacterial Infections (Bacterial Infection) 02/2019 - 07/2015
4	Multiple Sclerosis 01/2019 - 06/2010
3	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2018
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2015
3	Endotoxemia 02/2019 - 06/2006
3	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 08/2018 - 01/2011
2	Communicable Diseases (Infectious Diseases) 01/2024 - 01/2018
2	Leukemia 01/2024 - 02/2023
2	Persistent Infection 01/2024 - 09/2007
2	Cross Infection (Nosocomial Infection) 11/2023 - 01/2021
2	Suppuration 11/2022 - 01/2018
2	Urinary Tract Infections (Urinary Tract Infection) 11/2022 - 05/2019
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 01/2021
2	Mycoses (Diseases, Fungus) 12/2020 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2019 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2018 - 06/2010
2	Carcinogenesis 04/2018 - 02/2016
2	Wounds and Injuries (Trauma) 06/2011 - 12/2008
2	Meningitis 01/2011 - 12/2010
1	Lung Diseases (Lung Disease) 01/2024
1	Parasitic Diseases (Parasitic Disease) 06/2023
1	Leukopenia 02/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 11/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022
1	Pancreatitis 01/2022
1	Otitis Media 12/2021
1	Leukoplakia 07/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Hemolysis 01/2021
1	Tracheoesophageal Fistula 09/2020

Drug/Important Bio-Agent (IBA)

13	cerageninsIBA 02/2024 - 01/2016
13	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 09/2007
12	GelsolinIBA 02/2023 - 12/2008
10	CathelicidinsIBA 07/2022 - 02/2010
9	Peptides (Polypeptides)IBA 01/2024 - 06/2003
7	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 10/2005
7	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2022 - 06/2010
6	VimentinIBA 01/2024 - 06/2015
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2010
6	GoldIBA 01/2022 - 02/2019
6	Actins (F Actin)IBA 01/2018 - 10/2005
5	ceragenin CSA-13IBA 11/2022 - 09/2007
5	LipopolysaccharidesIBA 06/2010 - 07/2005
4	Antimicrobial PeptidesIBA 01/2023 - 06/2003
4	Antineoplastic Agents (Antineoplastics)IBA 10/2021 - 05/2016
4	CollagenIBA 07/2021 - 07/2014
3	EnzymesIBA 07/2022 - 08/2018
3	LigandsIBA 01/2022 - 02/2016
3	Indicators and Reagents (Reagents)IBA 04/2020 - 09/2010
3	SphingolipidsIBA 02/2019 - 03/2017
3	Deoxyribonucleases (DNase)FDA Link 01/2018 - 10/2005
3	LipidsIBA 03/2013 - 06/2010
2	SolutionsIBA 06/2023 - 05/2019
2	VaccinesIBA 06/2023 - 01/2023
2	SphingosineIBA 07/2022 - 12/2017
2	AntibodiesIBA 01/2022 - 03/2021
2	SARS-CoV-2 spike proteinIBA 01/2022 - 03/2021
2	ceragenin CSA-131IBA 10/2021 - 01/2020
2	ferric oxide (iron oxide)IBA 01/2020 - 02/2019
2	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2019 - 02/2019
2	CeramidesIBA 02/2019 - 12/2017
2	Vitamin D-Binding ProteinIBA 08/2018 - 01/2011
2	CytokinesIBA 10/2017 - 01/2013
2	IntegrinsIBA 10/2017 - 01/2014
2	Interleukin-8 (Interleukin 8)IBA 10/2017 - 06/2010
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 06/2010
2	Peptide Hydrolases (Proteases)FDA Link 03/2013 - 01/2013
2	Thrombin FDA Link 01/2013 - 06/2006
2	Clarithromycin (Biaxin)FDA LinkGeneric 09/2009 - 02/2007
1	pleurocidinIBA 01/2024
1	Expectorants (Mucolytics)IBA 01/2024
1	AntigensIBA 09/2023
1	Antiparasitic Agents (Antiparasitics)IBA 06/2023
1	Sodium Chloride FDA LinkGeneric 01/2023
1	polyacrylamideIBA 01/2023
1	HydrogelsIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2022
1	sphingosine kinaseIBA 07/2022
1	Virulence Factors (Pathogenicity Factors)IBA 06/2022
1	Adenylate KinaseIBA 01/2022
1	Proline Oxidase (Proline Dehydrogenase)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	resazurinIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	LactamsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021

Therapy/Procedure

13	Therapeutics 01/2024 - 01/2009
2	Oral Hygiene (Dental Hygiene) 02/2024 - 02/2007
2	Immunotherapy 02/2023 - 01/2021
2	Drug Therapy (Chemotherapy) 02/2023 - 01/2021
1	Antibiotic Prophylaxis 06/2022
1	Laryngectomy 09/2020